Intranasal Vaccine: Bharat Biotech Seeks Approval for Phase 3 Trials

Bharat Biotech has sought the approval of the Drug Controller General of India (DCGI) to conduct Phase 3 trials of its Covid-19 intranasal vaccine.

Related Keywords

India , , Intranasal Vaccine , Bharat Biotech Vaccines , Russian Vaccine Sputnik V , Covaxin , Covishield , Booster Vaccine ,